Plasma therapy player Ichor Biologics looks to raise $100-M

Hyderabad-based Ichor Biologics is planning to raise between USD 80-M and USD 100-M (INR 765 - INR 950 Cr) from private equity investors. The company has engaged Alvarez & Marsal to manage the fundraising process, which involves the sale of a significant minority stake.Founded in 2021, Ichor Biologics operates in the plasma-therapy segment, manufacturing therapeutic protein products at its facility in Shameerpet, Hyderabad. The company will use these funds to continue its operations, which include producing and marketing various therapeutic protein products for fields such as neurology, haematology, oncology, and immunology.